Compare FSI & CLNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | FSI | CLNN |
|---|---|---|
| Founded | 1991 | 2012 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Recreational Games/Products/Toys | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 63.7M | 67.5M |
| IPO Year | 2000 | 2021 |
| Metric | FSI | CLNN |
|---|---|---|
| Price | $5.50 | $4.44 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $33.75 |
| AVG Volume (30 Days) | 22.3K | ★ 73.6K |
| Earning Date | 04-15-2026 | 05-08-2026 |
| Dividend Yield | ★ 1.53% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $15,494,325.00 | $200,000.00 |
| Revenue This Year | $63.39 | $17.64 |
| Revenue Next Year | $43.77 | $19,516.77 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $4.85 | $3.88 |
| 52 Week High | $11.48 | $13.50 |
| Indicator | FSI | CLNN |
|---|---|---|
| Relative Strength Index (RSI) | 49.77 | 38.93 |
| Support Level | $5.24 | $3.92 |
| Resistance Level | $5.52 | $4.60 |
| Average True Range (ATR) | 0.20 | 0.38 |
| MACD | 0.07 | 0.02 |
| Stochastic Oscillator | 63.83 | 27.88 |
Flexible Solutions International Inc develops, manufactures, and markets specialty chemicals that slow the evaporation of water. Its business is organized into two segments: Energy and Water Conservation Products and Biodegradable Polymers. It offers a liquid swimming pool blanket under the WATERSAVR brand, which saves energy and water by inhibiting evaporation from the pool surface, and a chemical product called HEATSAV for use in swimming pools and spas to slow water evaporation. The company also manufactures and markets water-soluble chemicals utilizing thermal polyaspartate biopolymers. It generates the majority of its revenues from the export of its products to international markets.
Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. It developed an electro-crystal-chemistry drug development platform that enables the production of concentrated, stable, clean-surfaced nanocrystal suspensions. It operates in one segment the development and commercialization of dietary supplements (Supplements). Products includes CNM-Au8, CNM-ZnA, CNM-AgZn17, rMetx, KHC46.